AML blasts can express the enzymes arginase II and indoleamine 2,3 dioxygenase (IDO) which produce metabolites that hinder T cells while concurrently creating an environment that favors T regulatory cell and MDSC expansion which further dampen CAR T cell response and decrease proliferation. The gene discussed is IDO1; the disease is acute myeloid leukemia.